Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.442 USD | +4.99% | +1.94% | -40.28% |
Mar. 26 | Wall Street Set to Open Modestly Higher Tuesday Ahead Consumer Confidence Reading | MT |
Mar. 26 | US Futures Trend Higher Ahead of Durable Goods, House Prices, Consumer Confidence Readings | MT |
Financials (USD)
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.66M |
---|---|---|---|---|---|
Net income 2023 * | -12M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.06
x | P/E ratio 2024 * |
-
| Employees | 37 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Latest transcript on NeuBase Therapeutics, Inc.
1 day | +4.99% | ||
1 week | +1.94% | ||
Current month | -1.76% | ||
1 month | -55.80% | ||
3 months | -28.73% | ||
6 months | -34.03% | ||
Current year | -40.28% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 22-01-09 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 19-07-11 |
Eric Richman
BRD | Director/Board Member | 63 | 19-07-11 |
Director/Board Member | 79 | 19-07-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 0.442 | +4.99% | 25,641 |
24-04-24 | 0.421 | 0.00% | 21,218 |
24-04-23 | 0.421 | +0.24% | 58,425 |
24-04-22 | 0.42 | -2.33% | 157,792 |
24-04-19 | 0.43 | -0.83% | 88,885 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-40.28% | 1.66M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+47.53% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- NBSE Stock